Majeed Ammar, Castedal Maria, Arnelo Urban, Söderdahl Gunnar, Bergquist Annika, Said Karouk
a Center for Digestive Disease, Karolinska University Hospital, Karolinska Institutet , Stockholm , Sweden.
b Department of Medical Epidemiology and Biostatistics , Karolinska Institutet , Stockholm , Sweden.
Scand J Gastroenterol. 2018 Jan;53(1):56-63. doi: 10.1080/00365521.2017.1385840. Epub 2017 Oct 9.
Patients with primary sclerosing cholangitis (PSC) have increased risk of cholangiocarcinoma (CCA). We evaluated pre-transplant work-up in PSC patients, to search for the most effective strategy for the detection of biliary dysplasia or early CCA.
Two hundred and twenty five consecutive PSC patients undergoing liver transplantation (LTx) in Sweden between 1999 and 2013 were studied. Patients with CCA or dysplasia in the explanted liver were compared with those with benign histopathology. Measures of test performance were calculated for patients having brush cytology on one endoscopic retrograde cholangiopancreaticography (ERCP) occasion, for those having repeated examinations with or without cholangioscopy, and for fluorescence in situ hybridization (FISH). Survival after LTx was analyzed.
Brush cytology on a single ERCP occasion had moderate sensitivity (57%) and high specificity (94%) for the detection of CCA/high grade dysplasia (HGD) in the explanted liver. The corresponding sensitivity and specificity for FISH were 84% and 90%, respectively. Utilizing repeated ERCP and brush cytology to confirm the initial finding improved sensitivity to 82%. Using single operator cholangioscopy (SOC) for targeted examination at the second ERCP improved sensitivity (100%) and specificity (97%) significantly. Mortality rate in patients with incidentally discovered CCA (n = 16) in the explanted liver was significantly higher than in patients with HGD or benign histopathology (HR 16.0; 95% CI, 5.6-45.4; p < .001).
Repeated brush cytology especially when combined with targeted examination under SOC guidance is superior to single brush examinations. This strategy improves the detection of malignancy in PSC and is of importance for selection of patients for LTx.
原发性硬化性胆管炎(PSC)患者患胆管癌(CCA)的风险增加。我们评估了PSC患者移植前的检查,以寻找检测胆管发育异常或早期CCA的最有效策略。
对1999年至2013年期间在瑞典连续接受肝移植(LTx)的225例PSC患者进行了研究。将移植肝中患有CCA或发育异常的患者与组织病理学良性的患者进行比较。计算了在一次内镜逆行胰胆管造影(ERCP)时进行刷检细胞学检查的患者、进行有或无胆管镜检查的重复检查的患者以及荧光原位杂交(FISH)的患者的检测性能指标。分析了LTx后的生存率。
单次ERCP时的刷检细胞学检查对移植肝中CCA/高级别发育异常(HGD)的检测具有中等敏感性(57%)和高特异性(94%)。FISH的相应敏感性和特异性分别为84%和90%。利用重复ERCP和刷检细胞学检查来确认初始发现可将敏感性提高到82%。在第二次ERCP时使用单操作者胆管镜检查(SOC)进行靶向检查可显著提高敏感性(100%)和特异性(97%)。移植肝中偶然发现CCA(n = 16)的患者的死亡率显著高于HGD或组织病理学良性的患者(HR 16.0;95% CI,5.6 - 45.4;p <.001)。
重复刷检细胞学检查,尤其是在SOC引导下结合靶向检查,优于单次刷检。该策略可提高PSC中恶性肿瘤的检测率,对选择LTx患者具有重要意义。